Resources for Healthcare Providers
Young people ages 15 to 24 account for almost half of all cases of sexually transmitted infections (STIs). Health care providers can play a critical role in prevention by talking to patients about their sexual health; offering STI screening and treatment; and encouraging their patients to talk to their partners about prevention, screening and treatment. The resources here are designed to help you start those conversations and to link you to the latest screening and treatment guidelines.
CDC Treatment Guidelines
Provider Education & Training
Healthcare providers MUST report STIs to their local
Maryland regulations require healthcare providers to report chlamydia, gonorrhea, and syphilis infections within one business day. Reporting by laboratories does NOT nullify the healthcare provider’s obligation to report these diseases and conditions, nor does reporting by healthcare providers nullify the laboratory’s obligation to report.
To report a sexually transmitted notifiable disease, please complete both the general section of the DHMH 1140 morbidity report and the STI-specific section below it. The clinical and demographic information healthcare providers supply (which is normally unavailable from laboratories) enables the health department to better monitor disease trends and halt further transmission.
If you have a patient who recently tested positive for syphilis, gonorrhea, or chlamydia infection, the state or local health department may contact your office for additional information. Such information may include, confirmatory test results or treatment type and date of administration, as part of assuring comprehensive prevention and case management for your clients and their respective partners.
HIPAA and Disease Reporting
The HIPAA Privacy Rule permits physicians and other covered entities to disclose protected health information, without a patient's written authorization, to public health authorities who are legally authorized to receive such reports for the purpose of preventing or controlling disease. This includes conducting public health surveillance, investigations, or interventions.
For more about the privacy rule and public health see:
Intimate Partner Violence